LACTOSE.BO

Lactose (India) Limited

HealthcareMedical - PharmaceuticalsININRPeers →Country macro →

$108.45

Jun 05, 2026

AI Brief

Market cap

$1.37B

52w range

—

P / E

—

EPS · FY 2026

$4.68

Volume

—

Revenue · FY 2026

$1.63B

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Sentiment ESG

Explain this page

Arphra AIPlain-English read on Lactose (India) Limited’s valuation

Business description

· company · SEC profile

Lactose (India) Limited

Lactose India Ltd. engages in manufacturing of pharmaceutical and other pharmaceutical products. Its products include Excipient, Solid Dosage, Liquid Dosage, Active Pharmaceutical Ingredients, and Prebiotic-galacto-Oligosaccharides. The company was founded on March 11, 1991 and is headquartered in Mumbai, India.

Founded

—

IPO

Dec 30, 2024

Employees

129

Mumbai

CEO

Atul Surajmal Maheshwari

CFO

—

Exchange

BSE

Fiscal year

—

Identifiers

· company_identifiers

CIK

CUSIP—

ISININE058I01013

FIGILACTOSE IB

LEI—